Stockscreener 앱 받기
1.17
0.85%
-0.01
시간 외 거래:
1.17
전일 마감가:
$1.18
열려 있는:
$1.18
하루 거래량:
207.44K
Relative Volume:
0.46
시가총액:
$54.63M
수익:
-
순이익/손실:
-
주가수익비율:
-
EPS:
-
순현금흐름:
-
1주 성능:
-1.68%
1개월 성능:
-17.02%
6개월 성능:
-39.69%
1년 성능:
+0.00%
1일 변동 폭
$1.14
$1.239
1주일 범위
$1.05
$1.25
52주 변동 폭
$1.05
$2.99
Mindwalk Holdings Corp Stock (HYFT) Company Profile
Compare HYFT vs VRTX, REGN, ARGX, ALNY, ONC
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
HYFT
Mindwalk Holdings Corp
|
1.17 | 55.10M | 0 | 0 | 0 | 0.00 |
|
VRTX
Vertex Pharmaceuticals Inc
|
460.82 | 121.40B | 12.07B | 3.95B | 3.19B | 15.33 |
|
REGN
Regeneron Pharmaceuticals Inc
|
764.93 | 83.25B | 14.34B | 4.50B | 3.77B | 41.56 |
|
ARGX
Argen X Se Adr
|
728.11 | 46.39B | 4.16B | 1.29B | 734.26M | 19.59 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
320.51 | 43.41B | 3.71B | 313.75M | 465.38M | 2.2571 |
|
ONC
Beone Medicines Ltd Adr
|
292.94 | 33.09B | 5.36B | 287.73M | 924.18M | 2.5229 |
Mindwalk Holdings Corp Stock (HYFT) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2022-12-02 | 개시 | H.C. Wainwright | Buy |
| 2021-10-25 | 개시 | The Benchmark Company | Buy |
Mindwalk Holdings Corp 주식(HYFT)의 최신 뉴스
HYFT Forecast, Price Target & Analyst Ratings | MINDWALK HOLDINGS CORP (NASDAQ:HYFT) - ChartMill
HYFT SEC FilingsMindWalk Holdings Corp 10-K, 10-Q, 8-K Forms - Stock Titan
MindWalk Holdings to Report Q3 2026 Earnings - National Today
MindWalk Holdings Corp. to Report Third Quarter Fiscal Year 2026 Financial Results on March 12, 2026 - 01net
MindWalk Sets March 12 Date to Report Q3 2026 Results and Host Earnings Webcast - TipRanks
MindWalk (NASDAQ: IPA) sets March 12 call on Q3 FY 2026 results - Stock Titan
HYFT Technical Analysis & ETF Price Forecast - Intellectia AI
Zacks Research Upgrades MindWalk (NASDAQ:HYFT) to Hold - MarketBeat
Technology to Detect Functional Adjacency Linked to Portfolio Risk in AI-Designed Therapeutics - Business Wire
MindWalk Uses HYFT AI Platform to Expose Hidden Portfolio and IP Risks in Drug Discovery - TipRanks
MindWalk Applies HYFT® Technology to Detect Functional Adjacency Linked to Portfolio Risk in AI-Designed Therapeutics - Yahoo Finance
MindWalk Launches HYFT Technology to Address Drug Development Risks - intellectia.ai
HYFT Forecast — Price Prediction for 2026. Should I Buy HYFT? - Intellectia AI
After Leaping 47% MindWalk Holdings Corp. (NASDAQ:HYFT) Shares Are Not Flying Under The Radar - 富途牛牛
MindWalk Validates Platform Precision with Breakthrough Discovery Targeting Pathogenic TDP-43 in Neurodegenerative Disease - BioSpace
Mindwalk Validates Platform Precision with Breakthrough Discovery Targeting Pathogenic Tdp-43 in Neurodegenerative Disease - marketscreener.com
Scientists trace a hidden flu constraint across strains and hosts - Stock Titan
REPEAT/MindWalk Advances Universal Influenza Program with a Breakthrough Functional Insight - Yahoo Finance
MindWalk (HYFT) Makes Progress in Influenza Research with Key Di - GuruFocus
MindWalk Holdings Corp. Advances Universal Influenza Program with A Breakthrough Functional Insight - marketscreener.com
MindWalk Advances Universal Influenza Program with a Breakthrough Functional Insight - 01net
MindWalk Unveils Cross-Strain Functional Constraint to Advance Universal Flu Vaccine Effort - TipRanks
MindWalk : Charter of the Audit Committee of the Board of Directors - marketscreener.com
MindWalk Holdings Corp.'s (NASDAQ:HYFT) P/S Is Still On The Mark Following 38% Share Price Bounce - Sahm
MindWalk Holdings Corp. (HYFT) Competitors - Meyka
12 Health Care Stocks Moving In Monday's After-Market Session - Sahm
HYFT: MindWalk Holdings Corp.Balance Sheet - Zacks Investment Research
MindWalk Holdings Corp. 2026 Q2ResultsEarnings Call Presentation (NASDAQ:HYFT) 2025-12-18 - Seeking Alpha
MindWalk Holdings Corp. (HYFT) reports Q2 loss, lags revenue estimates - MSN
MindWalk : Second Quarter 2026 Transcript - marketscreener.com
MindWalk reports 54% revenue growth in Q2 fiscal 2026 By Investing.com - Investing.com Australia
MindWalk Holdings Corp.Common Stock (NQ: HYFT - Markets Financial Content
MindWalk Holdings Corp. (HYFT) Reports Q2 Loss, Lags Revenue Estimates - sharewise.com
MindWalk Holdings Corp (HYFT) Q2 2026 Earnings Call Highlights: Strong Revenue Growth and ... By GuruFocus - Investing.com Canada
MindWalk Holdings Corp (HYFT) Q2 2026 Earnings Call Highlights: Strong Revenue Growth and Strategic Innovations - GuruFocus
MindWalk Holdings Corp (HYFT) Q2 2026 Earnings Call Highlights: Strong Revenue Growth and ... - Yahoo Finance
HYFT Stock Price and Chart — NASDAQ:HYFT - TradingView — Track All Markets
Earnings call transcript: MindWalk’s Q2 2025 sees 54% revenue growth By Investing.com - Investing.com South Africa
Earnings call transcript: MindWalk’s Q2 2025 sees 54% revenue growth - Investing.com
MindWalk Holdings Corp. Reports Earnings Results for the Second Quarter and Six Months Ended October 31, 2025 - marketscreener.com
MindWalk Reports Record Growth and Announces Strategic Progress on Its AI Asset Pipeline - Business Wire
MindWalk reports 54% revenue growth in Q2 fiscal 2026 - Investing.com India
MindWalk Holdings (HYFT) Reports Strong Revenue Growth Despite E - GuruFocus
MindWalk Holdings Emphasizes AI-Driven Strategy in Latest Financial Release - TipRanks
MindWalk Holdings Corp. (HYFT) provides Q2 MD&A and financials update - Stock Titan
[6-K] MindWalk Holdings Corp. Current Report (Foreign Issuer) | HYFT SEC FilingForm 6-K - Stock Titan
Mindwalk Holdings Corp (HYFT) 재무 분석
Mindwalk Holdings Corp (HYFT)에 대한 금융 데이터가 없습니다. 더 많은 정보를 위해 다른 주식을 확인해보세요.
매출
순이익
현금흐름
주당 순 이익
3.69%
0.68%
자본화:
|
볼륨(24시간):